脑机接口试验受试者话语权不足,Ian Burkhart 欲推动改变
Patients have little say in how brain implant trials are done. Ian Burkhart wants to change that
作者 Ian Burkhart 自己就做过脑植入试验,他说受试者基本没参与试验设计,挺扎心的。如果你关注 Neuralink 这类 BCI 公司或参与过临床研究,这篇能让你看到患者视角,讨论怎么让试验更公平。
Ian Burkhart 成立了一个由脑植入物试验受试者组成的联盟,指出当前脑机接口(BCI)临床试验的设计和执行中,患者参与者几乎没有话语权。
他呼吁 BCI 设备开发方在研究流程中给予患者更多自主权和参与决策的空间。Burkhart 本人是脊髓损伤患者,曾参与脑植入物试验恢复手部运动,以亲身经历推动这一议题。
该主张指向一个具体矛盾:试验数据来自患者身体,但试验方案、撤出条件、数据使用权等关键决定往往由研发方主导。
Patients have little say in how brain implant trials are done. Ian Burkhart wants to change that
Ian Burkhart, founder of a coalition of brain implant trial participants, says device developers should give patients more agency in research.
This report is categorized under AITOP's "Industry" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows. Key entities and technical topics under continuous tracking include brain-computer interfaces, clinical trials, Ian Burkhart, Neuralink.
Source attribution: curated from STAT News · Health Tech (@O. Rose Broderick).